Skip to main content

Table 2 Characters of the 3 patients who developed relapse

From: Stage I seminoma: treatment outcome at King Hussein Cancer Center in Jordan

No. Age (years) T stage Ochiectomy approach Adjuvant radiotherapy field (dose) Pathological risk features Preoperative tumor markers Postoperative tumor markers Abnormality if tumor marker levels prior to relapse Method of detection of relapse Site of relapse Time from radiotherapy to relapse (months) Treatment Outcome (time at follow-up from relapse)
1 40 T1 Inguinal Para-aortic (20 Gy/10Fx) 4.6 cm tumor Normal Normal No CT scan Left hilum 25 Chemotherapy (BEPx4 cycles) ANED (32 months)
2 34 T2 Inguinal Para-aortic (20/10Fx) 6 cm tumor Not available Normal No CT scan Retro- peritoneal LN 8 Chemotherapy (BEPx4 cycles, TIPx4 cycles, VIPx4 cycles, GOPx8 cycles) DDD (25 months)
3 38 T2 Inguinal Para-aortic (20/10Fx) 8 cm tumor Normal Normal No Clinical examination Supra- clavicular LN 14 Chemotherapy (BEPx4 cycles) AWD (12 months)
  1. BEP: Bleomycin, Etoposide, Cisplatin, TIP: Paclitaxel, Ifosfamide, Cisplatin, VIP: Etoposide, Ifosfamide, Cisplatin, GOP: Gemcitabine, Oxaliplatin, Paclitaxel, ANED: Alive no evidence of disease, AWD: Alive with disease, DDD: Dead due to disease.